News & Updates

ANCHOR CRC: Triple therapy combo improves ORR in BRAF V600E-mutant mCRC

09 Sep 2020 by

The combination of encorafenib (ENCO) + binimetinib (BINI) + cetuximab (CETUX) improves objective response rate (ORR) in patients with BRAF^V600E-mutant metastatic colorectal cancer (mCRC) in the first-line setting, according to the ANCHOR CRC* trial presented at ESMO GI 2020.

ANCHOR CRC: Triple therapy combo improves ORR in BRAF V600E-mutant mCRC

09 Sep 2020

eXalt3: Ensartinib trumps crizotinib in ALK+ NSCLC

08 Sep 2020 by

In patients with locally advanced or metastatic ALK+ non-small cell lung cancer (NSCLC), treatment with the ALK tyrosine kinase inhibitor ensartinib led to superior progression-free survival (PFS) compared with crizotinib, according to interim results of the phase III eXalt3* trial.

eXalt3: Ensartinib trumps crizotinib in ALK+ NSCLC

08 Sep 2020

Aprepitant safe for subacute sclerosing panencephalitis, but efficacy yet to be determined

08 Sep 2020

Aprepitant is safe and well-tolerated for the treatment of subacute sclerosing panencephalitis, a recent study has found. Aside from modest improvements in electroencephalography outcomes, no strong clinical effect was observed.

Aprepitant safe for subacute sclerosing panencephalitis, but efficacy yet to be determined

08 Sep 2020

Are we winning the fight against COVID-19?

08 Sep 2020 by

Eight months into the pandemic, the world is still in the heat of fighting a contagion that we’ve no treatment for and no protection from. So far, what we’re able to achieve is a stalemate against COVID-19. Science remains our best hope – a vaccine against SARS-COV-2 with long-lasting protection.

Are we winning the fight against COVID-19?

08 Sep 2020

Oral masitinib helps for severe asthma uncontrolled on steroids

08 Sep 2020 by

The first-in-class tyrosine kinase inhibitor masitinib significantly reduces severe asthma exacerbations in patients who are uncontrolled on oral corticosteroids (OCS), regardless of their baseline eosinophil counts, according to a study presented at the ATS 2020 Virtual Meeting.

Oral masitinib helps for severe asthma uncontrolled on steroids

08 Sep 2020

Aspirin may accelerate cancer progression in elderly patients

08 Sep 2020

Use of aspirin in older adults with cancer may do more harm than good, exerting an adverse effect on later stages of cancer evolution, as reported in a study.

Aspirin may accelerate cancer progression in elderly patients

08 Sep 2020

Celecoxib better than diclofenac sodium for knee osteoarthritis

08 Sep 2020

Patients with knee osteoarthritis may experience better pain relief with celecoxib than with diclofenac sodium, in addition to having lower levels of inflammatory markers and complication risk, a study has found.

Celecoxib better than diclofenac sodium for knee osteoarthritis

08 Sep 2020

Egg intake does not increase T2D risk

08 Sep 2020

Moderate consumption of eggs is not largely associated with a heightened risk of type 2 diabetes (T2D), results of a systematic review and meta-analysis have shown.

Egg intake does not increase T2D risk

08 Sep 2020

Junior residents need more exposure to manage obstetric airway

08 Sep 2020 by

The local incidence of difficult intubation of patients delivering by caesarean section under general anaesthesia at a high-volume obstetric hospital in Singapore is 33 in 660 (1:20 or 5.0 percent), reports a recent study. No case of failed intubation has been recorded.

Junior residents need more exposure to manage obstetric airway

08 Sep 2020

Loss of smell, taste strong indicators of COVID-19

08 Sep 2020 by

Laboratory and radiological features are insufficient to distinguish the coronavirus disease 2019 (COVID-19) from other non-SARS-CoV-2 respiratory viral infections, according to a new Singapore study. On the other hand, anosmia and dysgeusia are reliable indicators of COVID-19.

Loss of smell, taste strong indicators of COVID-19

08 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

ANCHOR CRC: Triple therapy combo improves ORR in BRAF V600E-mutant mCRC

ANCHOR CRC: Triple therapy combo improves ORR in BRAF V600E-mutant mCRC

eXalt3: Ensartinib trumps crizotinib in ALK+ NSCLC

eXalt3: Ensartinib trumps crizotinib in ALK+ NSCLC

Aprepitant safe for subacute sclerosing panencephalitis, but efficacy yet to be determined

Aprepitant safe for subacute sclerosing panencephalitis, but efficacy yet to be determined

Are we winning the fight against COVID-19?

Are we winning the fight against COVID-19?

Oral masitinib helps for severe asthma uncontrolled on steroids

Oral masitinib helps for severe asthma uncontrolled on steroids

Aspirin may accelerate cancer progression in elderly patients

Aspirin may accelerate cancer progression in elderly patients

Celecoxib better than diclofenac sodium for knee osteoarthritis

Celecoxib better than diclofenac sodium for knee osteoarthritis

Egg intake does not increase T2D risk

Egg intake does not increase T2D risk

Junior residents need more exposure to manage obstetric airway

Junior residents need more exposure to manage obstetric airway

Loss of smell, taste strong indicators of COVID-19

Loss of smell, taste strong indicators of COVID-19